Novo Mesto — The Krka pharmaceutical company based in Novo Mesto and its Chinese partner Ningbo Menovo Pharmaceutical set up a joint venture Ningbo Krka Menovo Pharmaceutical. In total, 60% share in the new company belong to Krka. The initial capital of Ningbo Krka Menovo Pharmaceutical will amount to 30 million euros. A three-member board